IMI2 Launches Call 9
Call Identifier: H2020-JTI-IMI2-2016-09-two-stage
Publication Date: 1/05/2016
Budget: 117,656,000 €
Deadline: 26/07/2016 17:00  Brussels local Time
Stage 1 submission deadline: 26 July 2016
Specific Programme(s): Societal Challenges
Theme(s): Health, demographic change and wellbeing
Participant Portal

Please read the IMI2 Call 9 Topics Text  for full details of these topics, incuding the budget breakdown and the General Conditions for the Call for proposals.

Indicative budget

  • From EFPIA companies: EUR 59 328 000
  • From the IMI2 JU: EUR 58 328 000

Action Type:   RIA – Research and Innovation Actionsss

Topics:
  • Addressing the clinical burden of Clostridium difficile infection (CDI): Evaluation of the burden, current practices and set-up of a European research platform (part of the IMI New Drugs for Bad Bugs (ND4BB) programme)
  • Development of immune tolerance therapies for the treatment of rheumatic diseases
  • Data quality in preclinical research and development
  • Next generation of electronic translational safety
  • Identification and validation of biomarkers for non-alcoholic steatohepatitis (NASH) and across the spectrum of non-alcoholic fatty liver disease (NAFLD)
  • Joint influenza vaccine effectiveness studies

Provisions, proposal templates and evaluation forms

IMI2 Research and Innovation Actions (RIA) and Coordination and Support Actions (CSA) - relevant forms and templates

http://www.imi.europa.eu/content/stage-1-19

 

Video recordings of recent webinars on each topic are available from the IMI website.  



Jump to page content